Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children (Q48337182)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 December 2006

Language	Label	Description	Also known as
English	Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children	scientific article published on 14 December 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Dufourg MN

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Landman-Parker J

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Auclerc MF

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Schmitt C

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Perel Y

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Michel G

6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Levy P

7

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Couillault G

8

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Gandemer V

9

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Tabone MD

10

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Demeocq F

11

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Vannier JP

12

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Leblanc T

13

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Leverger G

14

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Baruchel A

15

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

publication date

14 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

21

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

238-247

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

Central Nervous System Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Cerebellar toxicity with high-dose cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Hemiparesis and ischemic changes of the white matter after intrathecal therapy for children with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Transient encephalopathy following a single exposure of high-dose methotrexate in a child with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Intrathecal Chemotherapy-Related Myeloencephalopathy in a Young Child with Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Acute encephalopathy during induction therapy for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Methotrexate treatment protocols and the central nervous system: significant cure with significant neurotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

High dose systemic methotrexate-associated acute neurologic dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Transient neurologic disturbances induced by high-dose methotrexate treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Acute transverse myelitis in children: clinical course and prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Acute ascending myelitis and encephalopathy after intrathecal cytosine arabinoside and methotrexate in an adolescent boy with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Paraplegia following intrathecal cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Excessive spinal cord toxicity from intensive central nervous system-directed therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic l

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Cerebral sinovenous thrombosis in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

21 January 2018

Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute leukemia in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of leukemic cells in the cerebrospinal fluid from children with acute lymphoblastic leukemia: advances and dilemmas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

7 January 2021

based on heuristic

inferred from DOI database lookup

Unexpected Acute Neurologic Toxicity in the Treatment of Children With Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

7 January 2021

based on heuristic

inferred from DOI database lookup

Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

7 January 2021

based on heuristic

inferred from DOI database lookup

Superior sagittal sinus thrombosis complicating maintenance treatment for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

7 January 2021

based on heuristic

inferred from DOI database lookup

New insights into paediatric haemostasis: thrombosis and bleeding issues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404495

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404495

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17170721

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48337182&oldid=2212109283"